Anya Miller
Head of Development
Replay available
Theravance Biopharma, Inc. (TBPH) Q4 2024 Earnings Call
Theravance Biopharma, Inc. (NASDAQ: TBPH) Q4 2024 earnings conference call, held 2025-02-26. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Rhonda Farnham
Chief Business Officer
Rick Winningham
Chief Executive Officer
David Reisinger
Analyst, Lee Ring Partners
Aziz Swaf
Chief Financial Officer
Julian Harrison
Analyst, PTIG
Douglas Tau
Analyst, HC Wainwright
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Theravance Biopharma, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.402 -- 00:00:04.647 Ladies and gentlemen, good afternoon. I'd like to welcome everyone to the Theravance 00:00:04.647 -- 00:00:09.732 Biopharma fourth quarter and full year 2024 conference call. 00:00:09.732 -- 00:00:13.436 During the presentation, all participants will be in a listen-only mode. 00:00:13.436 -- 00:00:17.380 A question and answer session will follow the company's formal remarks. 00:00:17.380 -- 00:00:21.124 To ask a question, press star 1-1 on your phone. 00:00:21.124 -- 00:00:26.309 Again, that's star 1-1 to ask a question. If listening via webcast, please mute 00:00:26.309 -- 00:00:30.594 audio on your webcast device before asking a question over the phone. 00:00:30.594 -- 00:00:35.240 I will repeat these instructions after management completes their prepared remarks. 00:00:35.240 -- 00:00:38.383 Also, today's conference call is being recorded. 00:00:38.383 -- 00:00:42.769 And now I'd like to turn the call over to Rick Winningham, Chief Executive Officer. 00:00:42.769 -- 00:00:45.329 Please go ahead, sir. 00:00:46.493 -- 00:00:51.980 Yeah, good afternoon, and welcome to Theravance Biopharma's fourth quarter 2024 Earnings 00:00:51.980 -- 00:00:57.275 Results Conference Call. On slide two, you'll find our forward-looking statements 00:00:57.275 -- 00:01:02.321 disclaimer, which covers certain risk factors, which could cause actual results 00:01:02.321 -- 00:01:07.706 to differ materially from any forward-looking statements we might make in today's call, 00:01:07.706 -- 00:01:12.371 and which are further described in our filings with the SEC. 00:01:12.371 -- 00:01:17.737 Moving to slide three, I'm joined today by Rhonda Farnham, Chief Business Officer, 00:01:17.737 -- 00:01:22.853 Anya Miller, Head of Development, and Aziz Swaf, Chief F...